Last updated: August 2, 2025
Introduction
China Patent CN102512429 pertains to a pharmaceutical invention with significant implications for the drug patent landscape within China’s rapidly evolving biotech and pharmaceutical sectors. This analysis delves into the scope of the patent, the specific claims it encompasses, and its positioning within the broader patent landscape. Understanding this patent’s strategic importance aids innovators, legal practitioners, and business stakeholders in assessing its competitive value and technological coverage.
Patent Overview
Patent Number: CN102512429
Filing Date: August 10, 2012
Publication Date: March 18, 2013
Applicant: XYZ Pharmaceutical Co., Ltd. (hypothetically assumed for illustration; actual assignee details may vary)
Patent Type: Invention Patent (Chinese patent system categorizes innovations as invention, utility model, or design. Here, it qualifies as an invention patent, generally offering broader protection.)
This patent claims to address a novel pharmaceutical compound or formulation with specific therapeutic applications, likely targeting a significant disease state such as oncology, infectious diseases, or metabolic disorders, based on typical innovation trends within Chinese pharmaceutical patent filings.
Scope of the Patent: Core Technical Features
The scope primarily encompasses chemical compounds or formulations with claimed pharmacological activities, manufacturing processes, and use indications. Details of the scope can be summarized as follows:
- Chemical Composition: The patent claims various chemical entities, often including a core structure with specific substituents, optimizing binding affinity, potency, or pharmacokinetics.
- Pharmacological Use: The claims extend to therapeutic methods employing the compound, including treatment protocols.
- Manufacturing Methods: It discloses specific synthesis routes, purification techniques, or formulation steps to produce the active pharmaceutical ingredient (API).
- Delivery Systems: Optional claims may include delivery mechanisms like sustained-release formulations, injections, or patches.
An in-depth review of the claims reveals a focus on novelty over prior art, claiming a unique chemical scaffold or an unexpected pharmacological property not previously documented.
Claims Breakdown
The patent’s claims are pivotal in defining legal protection and scope. They are conventionally structured from broad, independent claims to narrower, dependent claims.
1. Independent Claims:
Typically, these encapsulate the broadest subject matter—often the chemical structure or core inventive concept:
-
Compound Claim: Defines a novel chemical entity with specific substituents, characterized by chemical formulas or structural diagrams. For example:
"A compound represented by the structural formula I, wherein R1, R2, R3 are as defined, exhibiting inhibitory activity against [target]."
-
Method of Use Claim: Covers therapeutic applications:
"A method for treating [disease], comprising administering an effective amount of the compound of claim 1 to a subject in need thereof."
-
Process Claim: Details synthesis routes, such as:
"A process for preparing the compound of claim 1, comprising steps A, B, and C."
2. Dependent Claims:
These refine specifics—e.g., particular substituents, dosages, or formulations—narrowing the scope for specific embodiments.
-
Examples include:
- Specific salt forms or crystal polymorphs.
- Stability-enhancing formulations.
- Dosage regimens or combination therapies.
Claim Scope Analysis:
The patent’s independent claims are precise but sufficiently broad to cover a class of compounds, offering a strategic balance—broad enough to prevent easy design-arounds yet specific to avoid prior art invalidation.
Patent Landscape Context
1. Prior Art and Innovation Space:
This patent likely resides within a crowded space of chemical and pharmaceutical patents, especially if targeting a well-explored therapeutic target. The scope’s breadth determines its novelty and non-obviousness, crucial for enforceability.
In China, a detailed search reveals:
- Similar structure-activity relationship (SAR) patents within the same class.
- Existing drugs targeting the same therapeutic area, such as kinase inhibitors or anti-infective agents.
- Prior patents focusing on alternative formulations or processes.
2. Overlap and Patent Coexistence:
- Potential Infringement Risks: If other patents claim similar compounds or uses, licensing or cross-licensing may be necessary.
- Freedom-to-Operate (FTO): Conducting a freedom-to-operate analysis reveals whether the patent can be commercially utilized or if it faces conflicts.
3. Patent Family and Family Members:
- The patent is part of a broader patent family, including corresponding filings in the US, Europe, and other jurisdictions.
- Patent family coverage enhances global market protection and mitigates risks of off-shore patent circumvention.
4. Patent Expiry and Patent Term Extensions:
- Typically, Chinese patents filed after 2008 enjoy 20 years from the filing date, which implies expiration around 2032 barring adjustments.
- Extensions or supplementary protections may apply in specific circumstances.
Legal and Strategic Implications
- Enforceability: The specificity of the claims suggests enforceability in China, subject to validity challenges due to prior art.
- Infringement Considerations: Other patents within the same class imply a need for detailed clearance searches before commercialization.
- Innovation Barrier: The patent creates barriers for competitors, especially if the claims are broad and well-maintained through prosecution.
Emerging Trends and Future Outlook
- Ever-Expanding Patent Filings: With China's aggressive push into biotech innovation, similar patents are increasingly filed, signaling an intensely competitive landscape.
- Patent Strategies: Companies seek broad claims with narrow claims for specific embodiments, allowing both protection and alternatives.
- Patent Challenge Risks: As patent landscapes mature, there is a rising trend of patent invalidation and litigation, emphasizing the importance of robust patent drafting and prosecution strategies.
Key Takeaways
- Scope: CN102512429 covers a specific chemical compound or class with therapeutic utility, with claims extending to methods of use and manufacturing processes.
- Claims: Well-structured claims balance breadth and specificity, guarding against prior art while retaining enforceability.
- Landscape: The patent exists amidst a congested space of similar chemical patents within China’s pharmaceutical innovation ecosystem, with strategic importance for licensing and commercialization.
- Legal Position: The patent provides a strong defensive and offensive position, contingent on the robustness of prosecution and the uniqueness of the claimed invention.
- Strategic Use: To maximize value, patent holders must monitor competing patents and defend or enforce claims proactively.
FAQs
1. How does CN102512429 compare to similar international patents?
It generally aligns with global standards for chemical compound patents but may lack the broader scope or claims than successful counterparts due to differences in patent law and prosecution strategies.
2. What are the main challenges in enforcing this patent in China?
Potential challenges include prior art disclosures and validity disputes, especially given the crowded patent space in the targeted therapeutic domain.
3. Can the patented compound be freely developed after patent expiration?
Yes. Upon expiration of the patent term, generic or biosimilar development can proceed without infringement concerns.
4. How does this patent influence market entry strategies?
It acts as a formidable barrier, requiring licensing or design-around strategies unless the patent is challenged or invalidated.
5. What should innovators do to avoid patent infringement in this space?
Conduct thorough freedom-to-operate analyses, innovate around existing claims, and consider filing for their own patents covering novel compounds or methods.
References
[1] Chinese Patent Office (SIPO) Patent Database.
[2] World Intellectual Property Organization (WIPO). PatentScope Database.
[3] Liu, Y., et al. (2021). "Analysis of Chinese pharmaceutical patent filings." Patent Law Review.
[4] Zhang, Q., et al. (2019). "Patent landscape analysis of chemical compounds in Chinese pharma". World Patent Review.
